On World Alzheimer’s Day 2025, experts warn that not all forgetfulness is normal ageing. The Financial Express got in touch…
Saiyaara shows early-onset Alzheimer’s in a 22-year-old girl. Experts explain this rare but serious brain disorder that can affect young…
A new AI tool developed by Mayo Clinic can accurately detect different types of dementia, including Alzheimer’s, using brain scans,…
The Rapid Eye Movement (REM) stage is marked by quick movements of the eyes, increased activity in the brain and…
This suggests that Ozempic’s potential to slow or prevent disease progression.
Lipton and his colleagues are hopeful that this same treatment could be used for other conditions linked to inflammation –…
Maintaining healthy blood fat levels may be more important for brain health than previously thought, the authors suggested.
Alzheimer’s disease treatments aimed at activating liver proteins known to regulate cholesterol and lipid (fat) metabolism could help reduce amyloid…
Donanemab, given as an infusion every four weeks, has shown to slow down cognitive decline by 4-7 months in clinical…
The FDA approved a similar infused drug, Leqembi, from Japanese drugmaker Eisai last year.
Since 2005, BioArctic has a long-term collaboration with Eisai regarding the development and commercialization of drugs for the treatment of…
Globally, the number of people living with, or dying from, neurological conditions such as stroke, Alzheimer’s disease and other dementias,…
One of the first – an ongoing phase II clinical trial studying the effect of a herpes treatment on Alzheimer’s…
This study identifies dementia risk factors such as increased consumption of saturated fats, meat, particularly red meat.
A study underscores how visceral fat, deeply nestled within, can significantly impact brain health and its communication networks
The team developed an ultra-thin silicon chip containing “nanopores” that analyse the proteins one at a time with help from…
While Eisai set the price of the drug at $26,500 a year in the US, the cost in Japan will…
Reportedly, if the drug gets approved by the USFDA, it will become the third medication available to treat the condition…